Stocks In News - USFDA

1. The Alembic Pharmaceuticals has received approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amantadine Hydrochloride capsules, USP, 100 mg.
2. The approved ANDA is therapeutically equivalent to the reference listed drug product Symmetrel capsules, 100mg, of Endo Pharmaceuticals, Inc.
3. Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus.